Original Article
Original Article
/ VOLUME 8, ISSUE 5, SEPTEMBER 2026
Reyhan Balkaya Demirtaş and others
Antimicrobial resistance (AMR) is a critical global health threat, contributing to increased mortality and substantial economic costs. The World Bank has projected an additional USD 1 trillion in healthcare costs by 2050 [...] Read More
Original Article
/ VOLUME 8, ISSUE 5, SEPTEMBER 2026
Gamze Konyalı and others
Approximately 44 million people have died from acquired immunodeficiency syndrome (AIDS)-related illnesses resulting from infection with the human immunodeficiency virus (HIV). However, with increased access to effective prevention, diagnosis [...] Read More
Original Article
/ VOLUME 8, ISSUE 5, SEPTEMBER 2026
Merve Gürler and others
Staphylococcus aureus remains a leading cause of both community-acquired and healthcare-associated infections. Skin and soft tissue infections (SSTIs) account for a considerable proportion of outpatient clinic presentations [...] Read More
Original Article
/ VOLUME 8, ISSUE 5, SEPTEMBER 2026
Zehra Karacaer and others
Despite the transition of HIV/AIDS from a once-fatal condition to a manageable chronic disease through decades of pharmaceutical innovation, the social dimensions of the epidemic remain complex and multifaceted [...] Read More
Original Article
/ VOLUME 8, ISSUE 5, SEPTEMBER 2026
Nazife Duygu Demirbaş and others
Non-typhoidal serovars of Salmonella enterica are an important cause of morbidity and mortality worldwide. Although they typically cause self-limiting gastroenteritis, they can invade the bloodstream and other normally sterile [...] Read More
Original Article
/ VOLUME 8, ISSUE 5, SEPTEMBER 2026
Sümeyye Atasever-Yüce and others
Galectin-3 (Gal-3) is a lectin belonging to the β-galactoside-binding lectin family and was first identified in macrophages (1,2). It is encoded by the LGALS3 gene on chromosome 14. Like other galectins, Gal-3 exerts its effects [...] Read More
Original Article
/ VOLUME 8, ISSUE 4, JULY 2026
Dilşat Tepe and others
Granulomatous mastitis (GM) is a rare inflammatory disease of the breast. Lactation disorders resulting in milk stasis, hyperprolactinemia, and blunt trauma to the breast are recognized predisposing factors for GM. Radiological imaging, core [...] Read More
Original Article
/ VOLUME 8, ISSUE 4, JULY 2026
Leo Lui and others
Multidrug-resistant organisms (MDROs) are common causes of healthcare-associated infections (HAIs), which result in adverse patient outcomes, substantial morbidity and mortality, and increased healthcare-related costs. A growing body of literature [...] Read More
Original Article
/ VOLUME 8, ISSUE 4, JULY 2026
Ali Akar and Mustafa Serhat Şahinoğlu
Surgical site infections (SSIs) remain one of the most common and serious hospital-acquired infections (HAIs), despite continuous technological advancements in modern medicine. Depending on the type of surgery, the incidence [...] Read More
Original Article
/ VOLUME 8, ISSUE 4, JULY 2026
Mohd Khairi Safwan Johari and others
Tuberculosis (TB) remains a major global infectious disease and an important cause of preventable mortality. According to the World Health Organization (WHO) Global Tuberculosis Report 2025, an estimated 10.7 million people [...] Read More
Original Article
/ VOLUME 8, ISSUE 4, JULY 2026
Serpil S. Çuğlan and others
Acute bacterial meningitis (ABM) is a rapidly progressive disease with outbreak potential and remains associated with substantial morbidity and mortality worldwide. Although vaccination programs have significantly reduced the incidence of several major pathogens, ABM [...] Read More
Original Article
/ VOLUME 8, ISSUE 4, JULY 2026
Sait Anıl Ulus and others
Hydatid disease is a parasitic infection caused by Echinococcus granulosus and Echinococcus multilocularis. The life cycle of E. granulosus involves two main hosts: an intermediate host and a definitive host. Dogs are the most common [...] Read More
Original Article
/ VOLUME 8, ISSUE 4, JULY 2026
Nagihan Aka and others
Earthquakes are natural disasters that impact thousands of individuals. The mass destruction caused by earthquakes leads to a surge in admissions to healthcare facilities. In addition to direct structural damage, earthquake-related secondary [...] Read More
Original Article
/ VOLUME 8, ISSUE 3, MAY 2026
Aslı Çabuk and others
Enterobacterales are among the most important causative agents of both community-acquired and hospital-acquired infections. They are major causes of urinary tract infections and bloodstream infections, which are associated with significant morbidity and mortality. In particular, the development of carbapenem resistance [...] Read More
Original Article
/ VOLUME 8, ISSUE 3, MAY 2026
Damla Ertürk and others
Nontuberculous mycobacteria (NTM) are environmental mycobacterial species that exclude members of the Mycobacterium tuberculosis complex and Mycobacterium leprae. The incidence of NTM infections has increased worldwide [...] Read More
Original Article
/ VOLUME 8, ISSUE 3, MAY 2026
Yeliz Çiçek and others
Hepatitis B infection remains a major global public health burden. Hepatitis B virus (HBV) is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma, and contributes substantially to liver-related morbidit [...] Read More
Original Article
/ VOLUME 8, ISSUE 3, MAY 2026
Aysel Pehlivanlı and others
Solid organ transplantation (SOT) and hematopoietic stem cell transplantation (HSCT) are treatments that prolong survival and improve quality of life in patients with end-stage organ failure and hematologic malignancies respectively. Read More
Original Article
/ VOLUME 8, ISSUE 3, MAY 2026
Merve Arslan and others
According to the Centers for Disease Control and Prevention (CDC)'s 2024 report, healthcare-associated infections (HAIs) occur in 1 in 31 hospitalized patients and in 1 in 43 residents in long-term care facilities. HAIs represent [...] Read More
Original Article
/ VOLUME 8, ISSUE 3, MAY 2026
Nishteman Faysal Mohammad and Amir Hani Raziq
Tuberculosis (TB) remains one of the most serious infectious diseases worldwide and continues to represent a major public health challenge, particularly in low- and middle-income countries. According to the World Health Organization (WHO), approximately 10.6 million people developed TB globally in 2022, with an estimated 1.3 million deaths, making TB one of the leading causes [...] Read More
Original Article
/ VOLUME 8, ISSUE 2, MARCH 2026
Prabhav Aggarwal and others
The uncontrolled and unmonitored overuse of antimicrobials in healthcare, agriculture, and animal husbandry has led to a global health crisis, resulting in resistance to both commonly used and reserve antibiotics. Gram-negative bacteria have developed resistance to higher-tier agents, posing [...] Read More